{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:42:55Z","timestamp":1794433375178,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-56151-y","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:02:35Z","timestamp":1738922555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes"],"prefix":"10.1038","volume":"16","author":[{"given":"Elisa","family":"Molina Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-781X","authenticated-orcid":false,"given":"Joan Josep","family":"Bech-Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloi","family":"Franco-Trepat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7281-4028","authenticated-orcid":false,"given":"Ignasi","family":"Jarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4192-7622","authenticated-orcid":false,"given":"Daniel","family":"Perez-Zsolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Badia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Riveira-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0698-8710","authenticated-orcid":false,"given":"Edurne","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Revilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Tarr\u00e9s-Freixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0524-4018","authenticated-orcid":false,"given":"Gerardo","family":"Ceada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kochanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7656-5700","authenticated-orcid":false,"given":"D\u00e0lia","family":"Ra\u00efch-Regu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Erkizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rytis","family":"Boreika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni E.","family":"Bordoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4122-5079","authenticated-orcid":false,"given":"Laia","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2257-3331","authenticated-orcid":false,"given":"Sonia","family":"Guil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-5948","authenticated-orcid":false,"given":"Jorge","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-0217","authenticated-orcid":false,"given":"Juli\u00e0","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-4950","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6553-691X","authenticated-orcid":false,"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2405-878X","authenticated-orcid":false,"given":"Alejandro","family":"Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aviles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Vergara-Alert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1539-7261","authenticated-orcid":false,"given":"Joaquim","family":"Segal\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-4598","authenticated-orcid":false,"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-7363","authenticated-orcid":false,"given":"Ester","family":"Ballana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9363-291X","authenticated-orcid":false,"given":"Carolina","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1039-1821","authenticated-orcid":false,"given":"Nuria","family":"Izquierdo-Useros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"56151_CR1","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","volume":"16","author":"A Zumla","year":"2016","unstructured":"Zumla, A. et al. Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. Lancet Infect. Dis. 16, e47\u2013e63 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"56151_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","volume":"17","author":"SHE Kaufmann","year":"2018","unstructured":"Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S. & Bartenschlager, R. Host-directed therapies for bacterial and viral infections. Nat. Rev. Drug Discov. 17, 35\u201356 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"56151_CR3","doi-asserted-by":"publisher","unstructured":"Baggen, J., Vanstreels, E., Jansen, S. & Daelemans, D. Cellular host factors for SARS-CoV-2 infection. Nat. Microbiol. 1219\u20131232, https:\/\/doi.org\/10.1038\/s41564-021-00958-0 (2021).","DOI":"10.1038\/s41564-021-00958-0"},{"key":"56151_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"56151_CR5","unstructured":"Normile, D. Philanthropist donates $172 million to speed up drug development for the next pandemic (Scienceinsider, 2022)."},{"key":"56151_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0140-6736(19)32682-0","volume":"395","author":"L-G Bekker","year":"2020","unstructured":"Bekker, L.-G. et al. The complex challenges of HIV vaccine development require renewed and expanded global commitment. Lancet 395, 384\u2013388 (2020).","journal-title":"Lancet"},{"key":"56151_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/d41586-022-01898-3","volume":"607","author":"A Maxmen","year":"2022","unstructured":"Maxmen, A. Unseating big pharma: the radical plan for vaccine equity. Nature 607, 226\u2013233 (2022).","journal-title":"Nature"},{"key":"56151_CR8","doi-asserted-by":"publisher","unstructured":"Riva, L. et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature, https:\/\/doi.org\/10.1038\/s41586-020-2577-1. (2020).","DOI":"10.1038\/s41586-020-2577-1"},{"key":"56151_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468 (2020).","journal-title":"Nature"},{"key":"56151_CR10","doi-asserted-by":"publisher","first-page":"646676","DOI":"10.3389\/fphar.2021.646676","volume":"12","author":"J Rodon","year":"2021","unstructured":"Rodon, J. et al. Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen. Front. Pharmacol. 12, 646676 (2021).","journal-title":"Front. Pharmacol."},{"key":"56151_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.1141448","volume":"319","author":"WE Balch","year":"2008","unstructured":"Balch, W. E., Morimoto, R. I., Dillin, A. & Kelly, J. W. Adapting Proteostasis for Disease Intervention. Science 319, 916\u2013919 (2008).","journal-title":"Science"},{"key":"56151_CR12","doi-asserted-by":"publisher","first-page":"e202101200","DOI":"10.26508\/lsa.202101200","volume":"5","author":"JF Varona","year":"2022","unstructured":"Varona, J. F. et al. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19. Life Sci. Alliance 5, e202101200 (2022).","journal-title":"Life Sci. Alliance"},{"key":"56151_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-021-01220-0","volume":"15","author":"P Guisado-Vasco","year":"2022","unstructured":"Guisado-Vasco, P. et al. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia. J. Hematol. Oncol. 15, 4 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"56151_CR14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.abf4058","volume":"371","author":"KM White","year":"2021","unstructured":"White, K. M. et al. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science 371, 926\u2013931 (2021).","journal-title":"Science"},{"key":"56151_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105270","volume":"200","author":"M Sachse","year":"2022","unstructured":"Sachse, M. et al. Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis. Antivir. Res. 200, 105270 (2022).","journal-title":"Antivir. Res."},{"key":"56151_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep35100","volume":"6","author":"A Losada","year":"2016","unstructured":"Losada, A. et al. Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin. Sci. Rep. 6, 35100 (2016).","journal-title":"Sci. Rep."},{"key":"56151_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113744","volume":"172","author":"A Losada","year":"2020","unstructured":"Losada, A. et al. Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells. Biochemical Pharmacol. 172, 113744 (2020).","journal-title":"Biochemical Pharmacol."},{"key":"56151_CR18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1128\/jvi.57.1.328-334.1986","volume":"57","author":"SG Sawicki","year":"1986","unstructured":"Sawicki, S. G. & Sawicki, D. L. Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis. J. Virol. 57, 328\u2013334 (1986).","journal-title":"J. Virol."},{"key":"56151_CR19","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1074\/mcp.TIR119.001385","volume":"18","author":"J Zecha","year":"2019","unstructured":"Zecha, J. et al. TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach. Mol. Cell. Proteom. 18, 1468\u20131478 (2019).","journal-title":"Mol. Cell. Proteom."},{"key":"56151_CR20","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.chom.2020.11.003","volume":"28","author":"M Cortese","year":"2020","unstructured":"Cortese, M. et al. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies. Cell Host Microbe 28, 853\u2013866.e5 (2020).","journal-title":"Cell Host Microbe"},{"key":"56151_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-021-03610-3","volume":"594","author":"Y Finkel","year":"2021","unstructured":"Finkel, Y. et al. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. Nature 594, 240\u2013245 (2021).","journal-title":"Nature"},{"key":"56151_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nsmb.2214","volume":"19","author":"K Friend","year":"2012","unstructured":"Friend, K. et al. A conserved PUF\u2013Ago\u2013eEF1A complex attenuates translation elongation. Nat. Struct. Mol. Biol. 19, 176\u2013183 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"56151_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15730","volume":"8","author":"J Park","year":"2017","unstructured":"Park, J. et al. Misfolded polypeptides are selectively recognized and transported toward aggresomes by a CED complex. Nat. Commun. 8, 15730 (2017).","journal-title":"Nat. Commun."},{"key":"56151_CR24","doi-asserted-by":"publisher","first-page":"eaat5314","DOI":"10.1126\/science.aat5314","volume":"368","author":"M Costa-Mattioli","year":"2020","unstructured":"Costa-Mattioli, M. & Walter, P. The integrated stress response: From mechanism to disease. Science 368, eaat5314 (2020).","journal-title":"Science"},{"key":"56151_CR25","doi-asserted-by":"publisher","first-page":"e13367","DOI":"10.1111\/cpr.13367","volume":"56","author":"Y Liu","year":"2023","unstructured":"Liu, Y., Cui, J., Hoffman, A. R. & Hu, J. Eukaryotic translation initiation factor eIF4G2 opens novel paths for protein synthesis in development, apoptosis and cell differentiation. Cell Prolif. 56, e13367 (2023).","journal-title":"Cell Prolif."},{"key":"56151_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/nar\/gkq885","volume":"39","author":"K Gendron","year":"2011","unstructured":"Gendron, K., Ferbeyre, G., Heveker, N. & Brakier-Gingras, L. The activity of the HIV-1 IRES is stimulated by oxidative stress and controlled by a negative regulatory element. Nucleic Acids Res. 39, 902\u2013912 (2011).","journal-title":"Nucleic Acids Res."},{"key":"56151_CR27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer, K. D. et al. 5\u2032 UTR m6A Promotes Cap-Independent Translation. Cell 163, 999\u20131010 (2015).","journal-title":"Cell"},{"key":"56151_CR28","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. N6-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell 161, 1388\u20131399 (2015).","journal-title":"Cell"},{"key":"56151_CR29","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.chom.2016.04.002","volume":"19","author":"EM Kennedy","year":"2016","unstructured":"Kennedy, E. M. et al. Posttranscriptional m 6 A Editing of HIV-1 mRNAs Enhances Viral Gene Expression. Cell Host Microbe 19, 675\u2013685 (2016).","journal-title":"Cell Host Microbe"},{"key":"56151_CR30","doi-asserted-by":"publisher","unstructured":"Baek, A. et al. Single-molecule epitranscriptomic analysis of full-length HIV-1 RNAs reveals functional roles of site-specific m6As. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-024-01638-5 (2024).","DOI":"10.1038\/s41564-024-01638-5"},{"key":"56151_CR31","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1093\/nar\/gkac062","volume":"50","author":"C Pereira-Montecinos","year":"2022","unstructured":"Pereira-Montecinos, C. et al. Epitranscriptomic regulation of HIV-1 full-length RNA packaging. Nucleic Acids Res. 50, 2302\u20132318 (2022).","journal-title":"Nucleic Acids Res."},{"key":"56151_CR32","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/sj.gt.3301574","volume":"8","author":"J Bainbridge","year":"2001","unstructured":"Bainbridge, J. et al. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther. 8, 1665\u20131668 (2001).","journal-title":"Gene Ther."},{"key":"56151_CR33","doi-asserted-by":"publisher","first-page":"8552","DOI":"10.1128\/JVI.00819-16","volume":"90","author":"E Jimenez","year":"2016","unstructured":"Jimenez, E. et al. Non-human TRIM5 variants enhance recognition of HIV-1-infected cells by CD8+ T cells. J. Virol. 90, 8552\u20138562 (2016).","journal-title":"J. Virol."},{"key":"56151_CR34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/0008-5472.CAN-21-4249","volume":"83","author":"Y-G Hong","year":"2023","unstructured":"Hong, Y.-G. et al. The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression. Cancer Res. 83, 845\u2013860 (2023).","journal-title":"Cancer Res."},{"key":"56151_CR35","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng, H. et al. The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell 40, 1566\u20131582.e10 (2022).","journal-title":"Cancer Cell"},{"key":"56151_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.chom.2016.09.015","volume":"20","author":"NS Gokhale","year":"2016","unstructured":"Gokhale, N. S. et al. N6 -Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection. Cell Host Microbe 20, 654\u2013665 (2016).","journal-title":"Cell Host Microbe"},{"key":"56151_CR37","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.chom.2016.10.002","volume":"20","author":"G Lichinchi","year":"2016","unstructured":"Lichinchi, G. et al. Dynamics of Human and Viral RNA Methylation during Zika Virus Infection. Cell Host Microbe 20, 666\u2013673 (2016).","journal-title":"Cell Host Microbe"},{"key":"56151_CR38","doi-asserted-by":"publisher","first-page":"13123","DOI":"10.1074\/jbc.RA120.014260","volume":"295","author":"G-W Kim","year":"2020","unstructured":"Kim, G.-W., Imam, H., Khan, M. & Siddiqui, A. N6-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling. J. Biol. Chem. 295, 13123\u201313133 (2020).","journal-title":"J. Biol. Chem."},{"key":"56151_CR39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104805118","volume":"118","author":"KP Srinivas","year":"2021","unstructured":"Srinivas, K. P. et al. Widespread remodeling of the m 6 A RNA-modification landscape by a viral regulator of RNA processing and export. Proc. Natl Acad. Sci. USA 118, e2104805118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"56151_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12504-y","volume":"10","author":"M Xue","year":"2019","unstructured":"Xue, M. et al. Viral N6-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus. Nat. Commun. 10, 4595 (2019).","journal-title":"Nat. Commun."},{"key":"56151_CR41","doi-asserted-by":"publisher","first-page":"e01209","DOI":"10.1128\/mBio.01209-19","volume":"10","author":"DG Courtney","year":"2019","unstructured":"Courtney, D. G. et al. Extensive Epitranscriptomic Methylation of A and C Residues on Murine Leukemia Virus Transcripts Enhances Viral Gene Expression. mBio 10, e01209\u2013e01219 (2019).","journal-title":"mBio"},{"key":"56151_CR42","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41422-020-00465-7","volume":"31","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. The m6A methylome of SARS-CoV-2 in host cells. Cell Res. 31, 404\u2013414 (2021).","journal-title":"Cell Res."},{"key":"56151_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105232","volume":"197","author":"R Kumar","year":"2022","unstructured":"Kumar, R. et al. S-adenosylmethionine-dependent methyltransferase inhibitor DZNep blocks transcription and translation of SARS-CoV-2 genome with a low tendency to select for drug-resistant viral variants. Antivir. Res. 197, 105232 (2022).","journal-title":"Antivir. Res."},{"key":"56151_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46278-9","volume":"15","author":"B Baquero-P\u00e9rez","year":"2024","unstructured":"Baquero-P\u00e9rez, B. et al. N6-methyladenosine modification is not a general trait of viral RNA genomes. Nat. Commun. 15, 1964 (2024).","journal-title":"Nat. Commun."},{"key":"56151_CR45","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1128\/jvi.67.6.3338-3344.1993","volume":"67","author":"C Wang","year":"1993","unstructured":"Wang, C., Sarnow, P. & Siddiqui, A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. 67, 3338\u20133344 (1993).","journal-title":"J. Virol."},{"key":"56151_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10606-1","volume":"10","author":"Y Gordiyenko","year":"2019","unstructured":"Gordiyenko, Y., Ll\u00e1cer, J. L. & Ramakrishnan, V. Structural basis for the inhibition of translation through eIF2\u03b1 phosphorylation. Nat. Commun. 10, 2640 (2019).","journal-title":"Nat. Commun."},{"key":"56151_CR47","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.annonc.2021.07.003","volume":"32","author":"P Guisado-Vasco","year":"2021","unstructured":"Guisado-Vasco, P. et al. Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy. Ann. Oncol. 32, 1295\u20131297 (2021).","journal-title":"Ann. Oncol."},{"key":"56151_CR48","doi-asserted-by":"publisher","unstructured":"Landete, P. et al. A phase III randomized controlled trial of plitidepsin, a marine derived compound, in hospitalized adults with moderate COVID-19. Clin. Infect. Dis. ciae227, https:\/\/doi.org\/10.1093\/cid\/ciae227 (2024).","DOI":"10.1093\/cid\/ciae227"},{"key":"56151_CR49","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He, P. C. & He, C. m 6 A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 40, e105977 (2021).","journal-title":"EMBO J."},{"key":"56151_CR50","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/22221751.2021.2019559","volume":"11","author":"N Te","year":"2022","unstructured":"Te, N. et al. Enhanced replication fitness of MERS-CoV clade B over clade A strains in camelids explains the dominance of clade B strains in the Arabian Peninsula. Emerg. Microbes Infect. 11, 260\u2013274 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"56151_CR51","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jac\/dkv363","volume":"71","author":"R Badia","year":"2016","unstructured":"Badia, R. et al. Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1. J. Antimicrob. Chemother. 71, 387\u2013394 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"56151_CR52","doi-asserted-by":"publisher","first-page":"D561","DOI":"10.1093\/nar\/gkq973","volume":"39","author":"D Szklarczyk","year":"2011","unstructured":"Szklarczyk, D. et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39, D561\u2013D568 (2011).","journal-title":"Nucleic Acids Res."},{"key":"56151_CR53","doi-asserted-by":"publisher","first-page":"D373","DOI":"10.1093\/nar\/gkaa1007","volume":"49","author":"AM Altenhoff","year":"2021","unstructured":"Altenhoff, A. M. et al. OMA orthology in 2021: website overhaul, conserved isoforms, ancestral gene order and more. Nucleic Acids Res. 49, D373\u2013D379 (2021).","journal-title":"Nucleic Acids Res."},{"key":"56151_CR54","doi-asserted-by":"publisher","first-page":"W597","DOI":"10.1093\/nar\/gks400","volume":"40","author":"P Artimo","year":"2012","unstructured":"Artimo, P. et al. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res. 40, W597\u2013W603 (2012).","journal-title":"Nucleic Acids Res."},{"key":"56151_CR55","doi-asserted-by":"publisher","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"The Gene Ontology Consortium.","year":"2023","unstructured":"The Gene Ontology Consortium. et al. The Gene Ontology knowledgebase in 2023. GENETICS 224, iyad031 (2023).","journal-title":"GENETICS"},{"key":"56151_CR56","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. circlize implements and enhances circular visualization in. R. Bioinforma. 30, 2811\u20132812 (2014).","journal-title":"R. Bioinforma."},{"key":"56151_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"56151_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 12, 323 (2011).","journal-title":"BMC Bioinforma."},{"key":"56151_CR59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nprot.2007.517","volume":"3","author":"C Pannecouque","year":"2008","unstructured":"Pannecouque, C., Daelemans, D. & De Clercq, E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later. Nat. Protoc. 3, 427\u2013434 (2008).","journal-title":"Nat. Protoc."},{"key":"56151_CR60","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1128\/JVI.75.10.4614-4624.2001","volume":"75","author":"N Krieger","year":"2001","unstructured":"Krieger, N., Lohmann, V. & Bartenschlager, R. Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations. J. Virol. 75, 4614\u20134624 (2001).","journal-title":"J. Virol."},{"key":"56151_CR61","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1099\/vir.0.18997-0","volume":"84","author":"M Frese","year":"2003","unstructured":"Frese, M. et al. Hepatitis C virus RNA replication is resistant to tumour necrosis factor-\u03b1. J. Gen. Virol. 84, 1253\u20131259 (2003).","journal-title":"J. Gen. Virol."},{"key":"56151_CR62","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1128\/JVI.79.1.380-392.2005","volume":"79","author":"P Friebe","year":"2005","unstructured":"Friebe, P., Boudet, J., Simorre, J.-P. & Bartenschlager, R. Kissing-Loop Interaction in the 3\u2032 End of the Hepatitis C Virus Genome Essential for RNA Replication. J. Virol. 79, 380\u2013392 (2005).","journal-title":"J. Virol."},{"key":"56151_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112696","volume":"208","author":"M Nalli","year":"2020","unstructured":"Nalli, M. et al. New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains. Eur. J. Medicinal Chem. 208, 112696 (2020).","journal-title":"Eur. J. Medicinal Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56151-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56151-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:02:43Z","timestamp":1738922563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56151-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56151"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56151-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.A., J.V.-A. and N.I.\u2013U. are inventors in a patent application related to Aplidin\/Plitidepsin (EP20382821.5). N.I.\u2013U. and C.C. have collaborated with PharmaMar Foundation as part of a scientific jury. A.L., P.A. and C.C. are PharmaMar S.A. employees or PharmaMar S.A. shareholders or both. The authors declare no other competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1087"}}